Literature DB >> 16817054

Chronic paroxysmal hemicrania, hemicrania continua and SUNCT: the fate of the three first described cases.

Ottar Sjaastad1.   

Abstract

The first patient with chronic paroxysmal hemicrania has been followed for 45 years, and for 33 years with indomethacin treatment. The headache became less severe with time; there was no indomethacin tachyphylaxis. The first patient with SUNCT was followed for 28 years, until his demise at 89. Pain became worse with time. No adequate therapy was found. The first patient with Hemicrania continua was followed for 19 years, until her demise at 81. She was treated with indomethacin during the whole observation time. There was no tachyphylaxis. Both patients treated with indomethacin developed gastric ulcer. And both had gastric surgery. Indomethacin therapy may be a life-long affair. The risk of gastric complications may be substantial.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16817054      PMCID: PMC3451566          DOI: 10.1007/s10194-006-0303-5

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  2 in total

Review 1.  Focus on therapy: hemicrania continua and new daily persistent headache.

Authors:  Paolo Rossi; Cristina Tassorelli; Marta Allena; Enrico Ferrante; Carlo Lisotto; Giuseppe Nappi
Journal:  J Headache Pain       Date:  2010-02-26       Impact factor: 7.277

2.  Hemicrania continua: major shortcomings in the new classification.

Authors:  Torbjørn A Fredriksen; Fabio Antonaci; Ottar Sjaastad
Journal:  J Headache Pain       Date:  2014-09-13       Impact factor: 7.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.